In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.

GSK's potential cancer drug Jemperli cleared an important hurdle ahead of potentially receiving marketing permission from the European Medicines Agency.

GSK's cancer drug Jemperli cleared an important hurdle ahead of potentially expanding its European Union marketing permission, in a boost to the pharmaceutical giant's oncology pipeline.

Big pharma company GSK and UK AI-biotech Relation Therapeutics have entered into two strategic collaborations to identify and ...

Nine months out from landing $35 million in seed funding, Relation has more news – a big pharma collaboration. The group has ...

Dec 9 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Monday its experimental cancer drug Blenrep in combination with other treatments reduced the risk of death by 42% in multiple ...

2 pharmaceuticals market, for an initial term of 10 years. GSK's vaccines business has been held back by declining sales of shingles vaccine Shingrix in the United States and China, and a weaker ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

In November 2024, the European Commission approved GSK's single-vial, fully liquid Menveo vaccine (MenACWY). "Muna-GSK ...